Advancing laser therapies for ophthalmology
IRIDEX Corporation is a publicly traded (Nasdaq: IRIX) medical device company headquartered in Mountain View, California. Founded in 1989, the company is a worldwide leader in developing, manufacturing, and marketing innovative laser-based medical systems, delivery devices, and single-use consumables for the treatment of retinal diseases and glaucoma. Its product lines include the IQ 532, IQ 810, and IQ 577 laser systems powered by proprietary MicroPulse technology, which enables repeatable, tissue-sparing therapies. IRIDEX products are sold through a global network of distributors and direct sales teams.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountMar 2025
Mar 2025
Create a free account to see which investors have funded this company.
Create Free Account
operates in the healthcare industry focusing on biotechnology business
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
Healthcare company in Europe
Mehiläinen is a leading Finnish private healthcare company providing medical, health, and special...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Klick Health is a healthcare marketing and commercialization agency serving life sciences and pha...
